The role of 18F-FDG PET/CT in identifying risk factors for ground-glass nodules in invasive lung adenocarcinoma - Top-Institutions - MDSpire

The role of 18F-FDG PET/CT in identifying risk factors for ground-glass nodules in invasive lung adenocarcinoma

  • By

  • Wenjun Bao

  • Chenmin Ding

  • Nan Li

  • Min Huang

  • Zaosheng Huang

  • Hailong Li

  • Jing Fan

  • Tiantian He

  • Xibao Mao

  • July 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Changzhou Tumor Hospital
    Changzhou Tumor Hospital

    Changzhou, Jiangsu

    Key Differentiators

    • Oncology

  • #2

    Ruijin Hospital
    Ruijin Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Oncology

  • #3

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, Tennessee

    Key Differentiators

    • Oncology

  • #4

    American College of Surgeons Oncology Group
    American College of Surgeons Oncology Group

    Chicago, Illinois

    Key Differentiators

    • Oncology

  • #5

    Hunan Cancer Hospital
    Hunan Cancer Hospital

    Changsha, Hunan

    Key Differentiators

    • Oncology

Original Source(s)

The role of 18F-FDG PET/CT in identifying risk factors for ground-glass nodules in invasive lung adenocarcinoma

  • by Wenjun Bao, Chenmin Ding, Nan Li, Min Huang, Zaosheng Huang, Hailong Li, Jing Fan, Tiantian He, Xibao Mao

  • July 7, 2026

Related Content

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

  • by

  • July 7, 2026

  • 8 min
Assessment of growth and pain trajectories for children and adolescents receiving chemotherapy for acute lymphoblastic leukemia in Northern Thailand using group-based trajectory modeling

Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels